Related Experiment Video
Updated: Apr 28, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis
Pengfei Xu1, Haijun Yu1, Zhiwen Zhang1
1Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Abstract:
Metastasis is one of the major obstacles for the successful therapy of breast cancer. Although increased candidate drugs targeting cancer metastasis are tested, their clinical translation is limited by either serve toxicity or low efficacy. In present work, a nano-drug delivery system loading atorvastatin calcium (Ator) was developed for the efficient suppression of the metastasis of breast cancer. The nano-drug delivery system was constructed by a amphiphilic copolymer of methoxy polyethylene glycol-s-s-vitamin E succinate (mPEG-s-s-VES, PSV), which was consisted of a hydrophilic mPEG1k segment and a hydrophobic VES head, which were conjugated with a linker bearing amide and disulfide groups simultaneously. Self-assembly of PSV and Ator formed Ator-loaded PSV micelles (ASM) with good colloidal stability, high drug loading content (up to 50%) and great encapsulation efficiency (99.09 ± 0.28%). In cellular level, it was found that the ASM could efficiently release the Ator payload into cytosol due to detachment of PEG shell at high intracellular glutathione condition. ASM could significantly inhibit the migration and invasion of 4T1 breast cancer cells with inhibitory rates of 79.2% and 88.5%, respectively. In a 4T1 orthotropic mammary tumor metastatic cancer model, it was demonstrated that ASM could completely blocked the lung and liver metastasis of breast cancer with minimal toxicity owing to enhanced Ator accumulation in tumor and lung as compared with that of free Ator. The down-regulations of metastasis-promoting MMP-9, Twist and uPA proteins were demonstrated as the main underlying mechanism. As a result, ASM could be a promising drug delivery system for the efficient therapy of breast cancer metastasis.
Insights
A novel nano-drug delivery system effectively suppresses breast cancer metastasis. This system, loaded with atorvastatin calcium (Ator), shows high efficacy and minimal toxicity by targeting cancer cells and reducing metastasis-promoting proteins.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Metastasis is a primary challenge in breast cancer therapy, often limiting drug efficacy and causing toxicity.
- Existing treatments for cancer metastasis face hurdles in clinical translation due to toxicity and low effectiveness.
Purpose of the Study:
- To develop a nano-drug delivery system for efficient suppression of breast cancer metastasis.
- To load atorvastatin calcium (Ator) into a novel micelle system for enhanced therapeutic outcomes.
Main Methods:
- Constructed a nano-drug delivery system using mPEG-s-s-VES (PSV) copolymer to form atorvastatin calcium-loaded PSV micelles (ASM).
- Evaluated ASM's colloidal stability, drug loading, encapsulation efficiency, and in vitro drug release.
- Assessed the inhibition of 4T1 breast cancer cell migration and invasion, and evaluated metastatic blocking in a 4T1 orthotropic model.
- Investigated the underlying molecular mechanisms, including the downregulation of MMP-9, Twist, and uPA proteins.
Main Results:
- ASM exhibited good colloidal stability, high drug loading (up to 50%), and excellent encapsulation efficiency (99.09%).
- ASM efficiently released Ator intracellularly and significantly inhibited 4T1 cell migration (79.2%) and invasion (88.5%).
- In vivo studies demonstrated complete blockage of lung and liver metastasis with minimal toxicity, attributed to enhanced Ator accumulation in target tissues.
- Confirmed downregulation of metastasis-promoting proteins MMP-9, Twist, and uPA.
Conclusions:
- The developed Ator-loaded PSV micelles (ASM) represent a promising nano-drug delivery system for breast cancer metastasis therapy.
- ASM offers enhanced efficacy and reduced toxicity compared to free Ator, highlighting its potential for clinical application.
- The system effectively targets metastatic pathways, providing a novel strategy for managing advanced breast cancer.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Micelles
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drugs that Stabilize Microtubules

